Yan-dong Su - Publications

Analysis on the efficacy and safety of chemotherapy combined with or without bevacizumab after CRS+HIPEC in patients with malignant peritoneal mesothelioma: a single-center retrospective study.

Journal: Frontiers in oncology

Published: October 28, 2025

ASO Author Reflections: Cannot Be Overlooked-Increased Natural Killer Cell Infiltration is Linked to Improved Survival in Peritoneal Mesothelioma.

Journal: Annals of surgical oncology

Published: September 03, 2025

Elevated Proportion of Tumor-Infiltrating Natural Killer Cells Predicts Improved Survival in Peritoneal Mesothelioma: A Single-Center Study of 109 Cases.

Journal: Annals of surgical oncology

Published: July 07, 2025

Cisplatin + docetaxel improves survival over cisplatin + mitomycin C in hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei: a retrospective study based on propensity score matching.

Journal: International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group

Published: April 27, 2025

Dynamic evolution of NK cells and immune remodeling mediated by CRS + HIPEC: prognostic mechanisms and therapeutic implications for malignant peritoneal mesothelioma.

Journal: World journal of surgical oncology

Published: March 23, 2025

Clinical Significance of Tumor-Infiltrating Lymphocytes in Malignant Peritoneal Mesothelioma: A Single-Center Study of 143 Cases.

Journal: Annals of surgical oncology

Published: February 07, 2025

Efficacy of postoperative immunotherapy on MPM patients after CRS + HIPEC: A single-center retrospective study based on propensity score matching.

Journal: International journal of cancer

Published: January 18, 2025

Development in the Study of Natural Killer Cells for Malignant Peritoneal Mesothelioma Treatment.

Journal: Cancer biotherapy & radiopharmaceuticals

Published: August 02, 2024

Drug sensitivity tumor cell clusters in malignant peritoneal mesothelioma.

Journal: Journal of surgical oncology

Published: August 01, 2024

Effect of postoperative normothermic intraperitoneal chemotherapy on the prognosis of MPM patients receiving CRS+HIPEC: A single-center case-control study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: July 28, 2024

Prognostic Factors of Long-Term Survival and Conditional Survival Analysis in MPM Patients Treated with CRS+HIPEC: A Retrospective Study of Two Centers.

Journal: Annals of surgical oncology

Published: July 26, 2024

Intraoperative urinary tract resection and construction in CRS + HIPEC procedures: a single center retrospective analysis.

Journal: World journal of surgical oncology

Published: March 28, 2024